Acute kidney injury and the potential for ATF3-regulated epigenetic therapy

Toxicology Mechanisms and Methods

Volumn 21, Issue 4, 2011, Pages 362-366

  Cheng, Ching Feng ^a,b   Lin, Heng ^a,c  

^a TZU CHI UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ATF3; deacetylation; Epigenetic therapy; kidney injury

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CHEMOKINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; DNA VACCINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; HISTONE DEACETYLASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEIN P21; PROTEIN P50; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ALPHA VIRUS; ARTICLE; BINDING ASSAY; CELL PROTECTION; CHROMATIN STRUCTURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; EPIGENETICS; GENE THERAPY; IMMUNOPRECIPITATION; IMMUNOREGULATION; INTERSTITIAL NEPHRITIS; KIDNEY EPITHELIUM; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MACROPHAGE; MELANOMA; MESANGIUM CELL; NEPHRITIS; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PODOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; PROTEINURIA; RENAL PROTECTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; VASCULAR ENDOTHELIUM;

ACTIVATING TRANSCRIPTION FACTOR 3; ACUTE KIDNEY INJURY; ANIMALS; EPIGENESIS, GENETIC; HUMANS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 79954481568     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2011.557876     Document Type: Article

References (43)

1. Allen-Jennings AE, Hartman MG, Kociba GJ, Hai T. 2001. The roles of ATF3 in glucose homeostasis. A transgenic mouse model with liver dysfunction and defects in endocrine pancreas. J Biol Chem 276:29507-29514.
2. Brodsky SV, Yamamoto T, Tada T, Kim B, Chen J, Kajiya F, Goligorsky MS. 2002. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 282:F1140-F1149. (Pubitemid 34654480)
3. Chen BP, Liang G, Whelan J, Hai T. 1994. ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms. J Biol Chem 269:15819-15826.
4. Chen HH, Chen TW, Lin H. 2009. Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia- reperfusion injury. Am J Physiol Renal Physiol 297:F1109-F1118.
5. Chen SC, Liu YC, Shyu KG, Wang DL. 2008. Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide. Atherosclerosis 201:281-288.
6. Chu HM, Tan Y, Kobierski LA, Balsam LB, Comb MJ. 1994. Activating transcription factor-3 stimulates 3́,5́-cyclic adenosine monophosphate-dependent gene expression. Mol Endocrinol 8:59-68.
7. Djamali A. 2007. Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts. Am J Physiol Renal Physiol 293:F445-F455. (Pubitemid 47358116)
8. Fawcett TW, Martindale JL, Guyton KZ, Hai T, Holbrook NJ. 1999. Complexes containing activating transcription factor (ATF)/ cAMP-responsive-element- binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem J 339 (Pt 1):135-141. (Pubitemid 29179300)
9. Gilchrist M, Thorsson V, Li B, Rust AG, Korb M, Roach JC, Kennedy K, Hai T, Bolouri H, Aderem A. 2006. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441:173-178.
10. Hai T, Curran T. 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 88:3720-3724. (Pubitemid 21916695)
11. Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U. 1999. ATF3 and stress responses. Gene Expr 7:321-335. (Pubitemid 29372076)
12. Hai TW, Liu F, Coukos WJ, Green MR. 1989. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev 3:2083-2090. (Pubitemid 20023233)
13. Hsu JC, Bravo R, Taub R. 1992. Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol Cell Biol 12:4654-4665.
14. Hsu JC, Laz T, Mohn KL, Taub R. 1991. Identification of LRF-1, a leucine-zipper protein that is rapidly and highly induced in regenerating liver. Proc Natl Acad Sci USA 88:3511-3515. (Pubitemid 21916652)
15. Kelly KJ, Williams WW Jr, Colvin RB, Meehan SM, Springer TA, Gutierrez-Ramos JC, Bonventre JV. 1996. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 97:1056-1063. (Pubitemid 26070586)
16. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S. 2005. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115:2894-2903. (Pubitemid 41434417)
17. Leitner WW, Hwang LN, deVeer MJ, Zhou A, Silverman RH, Williams BR, Dubensky TW, Ying H, Restifo NP. 2003. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 9:33-39. (Pubitemid 36098257)
18. Li HF, Cheng CF, Liao WJ, Lin H, Yang RB. 2010. ATF3-mediated epigenetic regulation protects against acute kidney injury. J Am Soc Nephrol 21:1003-1013.
19. Li L, Huang L, Sung SS, Vergis AL, Rosin DL, Rose CE Jr, Lobo PI, Okusa MD. 2008. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury. Kidney Int 74:1526-1537.
20. Li L, Okusa MD. 2006. Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2A agonists. Nat Clin Pract Nephrol 2:432-444. (Pubitemid 44174535)
21. Lin H, Lee JL, Hou HH, Chung CP, Hsu SP, Juan SH. 2008. Molecular mechanisms of the antiproliferative effect of beraprost, a prostacyclin agonist, in murine vascular smooth muscle cells. J Cell Physiol 214:434-441. (Pubitemid 350309000)
22. Litvak V, Ramsey SA, Rust AG, Zak DE, Kennedy KA, Lampano AE, Nykter M, Shmulevich I, Aderem A. 2009. Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat Immunol 10:437-443.
23. Mayr B, Montminy M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2:599-609. (Pubitemid 33674011)
24. McCluskie MJ, Weeratna RD, Davis HL. 2000. The role of CpG in DNA vaccines. Springer Semin Immunopathol 22:125-132.
25. Nawa T, Nawa MT, Adachi MT, Uchimura I, Shimokawa R, Fujisawa K, Tanaka A, Numano F, Kitajima S. 2002. Expression of transcriptional repressor ATF3/LRF1 in human atherosclerosis: colocalization and possible involvement in cell death of vascular endothelial cells. Atherosclerosis 161:281-291. (Pubitemid 34219180)
26. Nawa T, Nawa MT, Cai Y, Zhang C, Uchimura I, Narumi S, Numano F, Kitajima S. 2000. Repression of TNF-alpha-induced E-selectin expression by PPAR activators: involvement of transcriptional repressor LRF-1/ATF3. Biochem Biophys Res Commun 275:406-411.
27. Nilsson M, Toftgård R, Bohm S. 1995. Activated Ha-Ras but not TPA induces transcription through binding sites for activating transcription factor 3/Jun and a novel nuclear factor. J Biol Chem 270:12210-12218.
28. Oh DJ, Dursun B, He Z, Lu L, Hoke TS, Ljubanovic D, Faubel S, Edelstein CL. 2008. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Renal Physiol 294:F264-F271.
29. Okusa MD, Linden J, Huang L, Rieger JM, Macdonald TL, Huynh LP. 2000. A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion. Am J Physiol Renal Physiol 279:F809-F818.
30. Rabb H. 2002. The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int 61:1935-1946. (Pubitemid 34539311)
31. Sanz AB, Sanchez-Niño MD, Ramos AM, Moreno JA, Santamaria B, Ruiz-Ortega M, Egido J, Ortiz A. 2010. NF-kappaB in renal inflammation. J Am Soc Nephrol 21:1254-1262.
32. Schrier RW, Wang W, Poole B, Mitra A. 2004. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 114:5-14. (Pubitemid 39071636)
33. Singbartl K, Green SA, Ley K. 2000. Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J 14:48-54. (Pubitemid 30051522)
34. Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC, Molitoris BA. 2003. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 285:F191-F198. (Pubitemid 36871191)
35. Thadhani R, Pascual M, Bonventre JV. 1996. Acute renal failure. N Engl J Med 334:1448-1460. (Pubitemid 126590563)
36. Thurman JM, Lenderink AM, Royer PA, Coleman KE, Zhou J, Lambris JD, Nemenoff RA, Quigg RJ, Holers VM. 2007. C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ischemia/reperfusion. J Immunol 178:1819-1828. (Pubitemid 46154654)
37. Whitmore MM, Iparraguirre A, Kubelka L, Weninger W, Hai T, Williams BR. 2007. Negative regulation of TLR-signaling pathways by activating transcription factor-3. J Immunol 179:3622-3630.
38. Wolfgang CD, Chen BP, Martindale JL, Holbrook NJ, Hai T. 1997. gadd153/Chop10, a potential target gene of the transcriptional repressor ATF3. Mol Cell Biol 17:6700-6707. (Pubitemid 27451217)
39. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ. 2007. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117:2847-2859. (Pubitemid 47529615)
40. Yang CC, Hsu SP, Wu MS, Hsu SM, Chien CT. 2006. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysisinduced oxidative stress. Kidney Int 69:706-714.
41. Yin T, Sandhu G, Wolfgang CD, Burrier A, Webb RL, Rigel DF, Hai T, Whelan J. 1997. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 272:19943-19950. (Pubitemid 27340095)
42. Yoshida T, Sugiura H, Mitobe M, Tsuchiya K, Shirota S, Nishimura S, Shiohira S, Ito H, Nobori K, Gullans SR, Akiba T, Nitta K. 2008. ATF3 protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 19:217-224. (Pubitemid 351240643)
43. Zhou H, Cheruvanky A, Hu X, Matsumoto T, Hiramatsu N, Cho ME, Berger A, Leelahavanichkul A, Doi K, Chawla LS, Illei GG, Kopp JB, Balow JE, Austin HA 3rd, Yuen PS, Star RA. 2008. Urinary exosomal transcription factors, a new class of biomarkers for renal disease. Kidney Int 74:613-621.